To evaluate the efficacy of a moisturizing cream in the treatment of Eczema.
- Conditions
- Other and unspecified dermatitis,
- Registration Number
- CTRI/2021/06/034406
- Lead Sponsor
- Dr Reddys Laboratories Ltd
- Brief Summary
**Day 0**
- Explanation of the Study and procedures.
- Collection of Informed consent
- Selection of volunteers by Inclusion/ exclusion criteria.
- Participants will be randomized into 2 groups based on their EASI scores - One group will get prescribed treatment with moisturizing cream and other group will get only prescribed treatment without any moisturizing cream.
- Baseline EASI scores
- Instrumental readings using MMSC and VapoMeter
- Administration of self-assessment questionnaire to evaluate itching and burning sensation.
**Week 2 and Week 4**
- Same parameters as mentioned above were measured.
- Products were retrieved from the participants.
Conclusion:
When compared to baseline, Venusia Max Cream used as an adjuvant along with standard
treatment significantly reduced the EASI score, significantly increased the skin hydration
measured by MMSC and significantly reduced the trans epidermal water loss measured by
VapoMeter. It also significantly showed reduction in 5D pruritus and burning sensation in
self-assessment score.
Clinical dryness self-assessment score has been done using a binary scale. There was no
change in dryness perception by the participants in both the groups after the treatment.
Also, Venusia Max Cream improved the skin hydration significantly on Eczematous skin of
patients and significantly reduced the 5D Pruritis score compared to the group where
Venusia Max Cream was not used as an adjuvant along with standard treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
Voluntary men and women with Atopic Dermatitis, Eruptive Eczema, Chronic Lichenified Eczema, Lichen Simplex Chronicus, Discoid Eczema, Allergic Eczema, with EASI scores 8 -21 or more.
- Pregnant women by UPT, Lactating mothers Participants with dry skin.
- Localised psoriasis patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical evaluation Day 0, Week 2, Week 4 Instrumental evaluation for Skin Hydration and Trans epidermal water loss Day 0, Week 2, Week 4 Self-Assessment (cutaneous dryness, Itching, Burning) Day 0, Week 2, Week 4
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Skin Clinic
🇮🇳Nashik, MAHARASHTRA, India
Skin Clinic🇮🇳Nashik, MAHARASHTRA, IndiaDr Suneel VartakPrincipal investigatorsuneel.vartak@gmail.com